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http://ccforum.com/content/18/2/R54RESEARCH Open AccessDecreased cardiac excitability secondary to
reduction of sodium current may be a significant
contributor to reduced contractility in a rat model
of sepsis
Andrew Koesters, Kathrin L Engisch and Mark M Rich*Abstract
Introduction: Multisystem organ failure remains a poorly understood complication of sepsis. During sepsis, reduced
excitability contributes to organ failure of skeletal muscle, nerves and the spinal cord. The goal of this study was to
determine whether reduced excitability might also contribute to cardiac failure during sepsis.
Methods: Wistar rats were made septic by cecal ligation and puncture. One day later, action potentials were
recorded from beating left ventricular papillary muscle ex vivo by impaling myocytes with sharp microelectrodes.
Results: In cardiac papillary muscle from septic rats, action potential amplitude and rate of rise were reduced, while
threshold was elevated. These changes in action potential properties suggest sepsis selectively reduces sodium current.
To determine the effects of selective reduction in sodium current, we applied tetrodotoxin to papillary muscle from
healthy rats and found reduction in action potential amplitude and rate of rise, as well as elevation of threshold. The
changes were similar to those triggered by sepsis. Blocking calcium current using nifedipine did not mimic action
potential changes induced by sepsis. Contractility of healthy papillary muscle was reduced to 40% of normal following
partial block of sodium current by tetrodotoxin, close to the low contractility of septic papillary muscle, which was 30%
of normal.
Conclusions: Our data suggest cardiac excitability is reduced during sepsis in rats. The reduction in excitability appears
to be primarily due to reduction of sodium current. The reduction in sodium current may be sufficient to explain most
of the reduction in cardiac contractility during sepsis.Introduction
Multisystem organ failure is a devastating complication
of critical illness. The mechanisms underlying multisystem
organ failure remain mysterious with no unifying hypoth-
esis to explain its occurrence. We and others have shown
there is reduction in excitability of skeletal muscle in both
patients and animal models of critical illness [1-5]. More
recently, we and others have also shown there is reduction
in excitability of peripheral nerve in both patients and
an animal model of sepsis [6,7]. Additionally, we recently
demonstrated reduction in motor neuron excitability within
the central nervous system in septic rats [8]. These studies* Correspondence: mark.rich@wright.edu
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unless otherwise stated.suggest reduced excitability occurs within multiple elec-
trically active tissues during critical illness.
In rat models of critical illness it has been possible to
determine the defect underlying reduced excitability. In
both peripheral nerve and skeletal muscle the defect
appears to be reduction in Na current due to altered
voltage dependence of inactivation of channels [7,9-12].
These studies raise the possibility that an acquired Na
channelopathy may be a common consequence of critical
illness that occurs in multiple electrically active tissues.
While it is known that severe sepsis causes cardiac
dysfunction [13-16], there have been no studies directly
examining excitability of the heart during critical illness.
We previously performed a retrospective study of elec-
trocardiogram (ECG) changes in patients during and
following recovery from sepsis and found reversiblel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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duration [17]. These changes are consistent with reduction
of cardiac excitability, but other interpretations such
as reduction in QRS amplitude secondary to anasarca
cannot be ruled out [18,19]. Here, we used a rat model
of sepsis to directly measure changes in cardiac excitability
during sepsis. The data suggest that during sepsis cardiac
excitability is decreased due to a reduction in Na current,
and reduction in Na current alone can reduce contractility.
Materials and methods
Induction of sepsis
All animal protocols were approved by the Institutional
Animal Care and Use Committee at Wright State Univer-
sity (Animal Assurance number A3632-01). Sepsis was
induced in isoflurane-anesthetized adult female Wistar
rats (250 to 300 grams) by cecal ligation and puncture
as described previously [7]. For continuous relief of pain,
an Alzet 2 mL osmotic pump (Durect Corp., Cupertino,
CA, USA) that delivered 20 μg/kg/hr of hydromorphone
was inserted into the abdomen prior to closing the
incision. At the end of surgery, rats were given a single
dose of buprenorphine (0.12 mg/kg) subcutaneously for
pain relief until the hydromorphone took effect. Rats were
studied one day after induction of sepsis as we have found
previously that one day is sufficient to induce reduction
of motoneuron excitability [8]. A subset of rats did not
survive 24 hours after induction of sepsis and only rats
exhibiting severe signs of sepsis 24 hours after cecal
ligation and puncture were euthanized and used for
experiments. Rats were determined to be severely septic
and killed for experiments when they exhibited piloerection
of the pelt, a hunched stance, little to no spontaneous
movement, and had a blunted response to touching
and handling.
Preparation of left ventricular papillary muscle
One day after cecal ligation and puncture, rats were eu-
thanized via CO2 asphyxiation, and hearts were removed
and placed into a Ca2+-free phosphate-buffered solution
to wash away excess blood. The papillary muscle was
removed and pinned at each end; then perfused with a
low-Ca2+ solution containing (in mM): NaCl (118), KCl
(3.5), MgSO4 (0.7), NaH2PO4 (1.7), NaHCO3 (26.2), dex-
trose (5.5), CaCl2 (0.375), and 2,3-butanedione monoxime
(BDM) (Sigma-Aldrich, St Louis, MO, USA) 5 mM); then
bubbled with 95% O2 and 5% CO2. Bath temperature was
22°C, pH was 7.4. This temperature was chosen as we
found that excitability of papillary muscle was difficult to
maintain over time at warmer temperatures. 4-Di-2ASP
(DiASP, Molecular Probes, Eugene, OR, USA) (10 μM)
was added to the bathed muscle for 3 to 4 minutes to
allow for visualization of cardiac muscle using epi-
fluorescence. We use this dose of 4-Di-2ASP routinelyfor imaging of skeletal muscle fibers and neuromuscular
junctions during recordings of muscle fiber action poten-
tials [5,20]. The papillary muscle was perfused with low-
Ca2+ solution containing BDM for 15 minutes, followed
by 15 minutes of perfusion with low-Ca2+ solution without
BDM. The inclusion of BDM greatly improves viability
of preparations [21,22]. Following low-Ca perfusion, we
perfused for 10 minutes with solution containing normal
extracellular Ca2+ (1.5 mM). Muscles were then paced for
1 hour using 1 ms current pulses generated by a stimulus
isolation unit (model A360 WPI Inc., Sarsota, FL, USA)
and delivered via a bipolar extracellular concentric elec-
trode (FHC Inc., Bowdoin, ME, USA) with a stimulation
rate of 1 Hz. The electrode was placed near the end of the
muscle and the stimulus was set at 1.5x the minimum
strength necessary to elicit maximal muscle contraction.
Muscle twitch was monitored over the next 1-hour period
and stimulus strength was gradually decreased as muscle
excitability recovered [23]. As BDM decreases cardiac
contractility [24], papillary muscles were perfused in solu-
tion lacking BDM for 1.5 hours prior to force measure-
ments. Using the above protocol, excitability of papillary
muscles was stable for greater than 2 hours at 22°C.
Intracellular recording from cardiomyocytes
After pacing for 1 hour, muscles were imaged using an
upright epifluorescence microscope (Leica Microsystems,
Bannockburn, IL, USA). Myocytes were impaled using
sharp electrodes filled with 3 M KCl solution and con-
taining sulforhodamine (1 mM) to allow for visualization
of the tip. Tip resistances were between 15 to 35 MΩ,
and capacitance compensation was optimized for each
electrode prior to recording. Myocytes were impaled
with a single electrode while pacing of the papillary
muscle continued, and action potentials were recorded
using a Gene Clamp 500B amplifier (Axon Instruments/
Molecular Devices, Sunnyvale, CA, USA), and a custom
software package (M. Pinter, Emory University). In a sub-
set of fibers, pacing was briefly turned off and membrane
time constant was measured by impaling single myocytes
with two sharp electrodes and measuring the membrane
response to a 10 ms injection of hyperpolarizing current.
Pacing was restarted after each recording and continued
for 2 to 3 minutes before impaling the next fiber.
Effects of tetrodotoxin and nifedipine on action
potentials and contractility in healthy muscle
After recording action potentials from four to six fibers,
tetrodotoxin (TTX, 5 μM, Tocris Cookson, Ellisville, MO,
USA), or nifedipine (10 μM, Sigma-Aldrich) was added
to the perfusate. After 7 to 10 minutes, action potentials
were recorded from an additional five to eight fibers.
The papillary muscle from each rat served as its own
control. To determine the effect of TTX and nifedipine
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linear motor with force transducer (Model 305B-LR,
Aurora Scientific, Aurora, ON, Canada) on one end so
that force could be recorded during pacing. Muscle
length was measured in the heart prior to removal, and
ex vivo length was adjusted by a motor on the force
transducer to equal the in situ length. After 1 hour of
pacing, force generated was recorded at several lengths
to identify the length that produced maximal force.
Once length was optimized, force was recorded; then
TTX (5 μM) was added to the perfusate and allowed to
equilibrate for 15 minutes. Force was recorded; TTX
was then washed out for 15 minutes, and force was
again recorded. Nifedipine (10 μM) was then added to
the perfusate and allowed to equilibrate for 15 minutes.
Force was recorded; nifedipine was then washed out for
1 to 2 hours, and final force record was recorded.
Measurement of papillary muscle force was performed
using Spike5 software (Cambridge Electronic Design,
Cambridge, UK).
Data analysis and sample size
Action potential data were analyzed using OriginPro 8
(OriginLab Corp., Northampton, MA, USA). Fibers with
resting potentials more depolarized than −72 mV were
excluded from analysis. Less than 10% of fibers were
discarded in healthy and septic rats. Action potential rate
of rise (dV/dt) was determined by taking the derivative of
voltage with respect to time using Origin software. Action
potential threshold was defined as the voltage at which
dV/dt was >10 mV/ms. In each papillary muscle, action
potentials were measured from at least four fibers. An
average value was then obtained for each parameter for
each papillary muscle. Animal average data were tested for
normal distribution and parameters were compared in
control vs. septic rats using the papillary muscle means for
an unpaired Student’s t test, with n as the number of rats
studied. For the study of sepsis versus control at least 80
muscle fibers were recorded from for each condition. For
the TTX and nifedipine studies, each rat served as its own
control and a paired Student’s t test was used. A paramet-
ric test was used as the larger control data set suggested
the values studied were normally distributed. In these
studies at least 14 muscle fibers were recorded from for
each condition.
Results
To directly study excitability and contractility of the heart,
left ventricular papillary muscle was taken from control
rats and rats killed 24 hours after induction of sepsis by
cecal ligation and puncture. The excised muscle was
paced at 1 Hz using an extracellular bipolar electrode
and action potential characteristics were measured with
sharp electrodes. In muscle from septic rats, actionpotentials were reduced in amplitude by 18.9 mV, thresh-
old was elevated by 7 mV and rate of rise was decreased
by 57% (Figure 1, Table 1). Depolarization during cardiac
action potentials is caused by opening of both Na and
Ca channels. Na channels open more rapidly and are
primarily responsible for early attributes of the action
potential, including threshold and maximal rate of rise
(dV/dt) [25,26]. Changes in these properties suggest
reduction in Na current in papillary muscle is the primary
mechanism underlying reduction of excitability.
To determine the effects of selective reduction in Na
current on action potential characteristics from healthy
rats we applied the specific Na channel blocker tetrodo-
toxin (TTX) [27] to reduce Na current. The Kd of TTX
for cardiac Na channels (Nav1.5) is close to 2 μM [28,29],
such that 5 μM TTX blocks close to 70% of Na channels.
Partial block of Na channels with 5 μM TTX reduced
action potential amplitude, elevated threshold and reduced
the maximal rate of action potential rise (Table 1). The
changes were similar in magnitude to those seen in the
most severely affected papillary muscles from septic rats.
A number of ion channels in addition to Na channels
determine the characteristics of cardiac action potentials.
These include non-voltage gated K channels involved
in baseline properties such as membrane potential and
specific membrane resistance as well as voltage gated K and
Ca channels that contribute to action potential duration
[30]. To determine the contribution of these other channels
we measured passive membrane properties, action potential
duration, and we pharmacologically blocked L-type Ca
channels. Sepsis did not induce changes in passive
membrane properties and there was no significant
depolarization of the resting potential (Table 1). The
slight decrease in membrane resistance as estimated
by membrane time constant did not reach significance and
was not of a magnitude that would significantly reduce
excitability (0.90 ± 0.12 ms in healthy vs. 0.78 ± 0.05 ms in
septic, P = 0.42, n = 3 rats for each group). In addition,
the slight decrease in action potential duration was not
statistically significant (P = 0.38, Table 1). The lack of
changes in passive membrane properties and action
potential duration suggest sepsis does not trigger dramatic
changes in K or Ca currents. To confirm that reduction
in Ca current could not account for the reduction in
excitability induced by sepsis we measured action poten-
tials in papillary muscle before and after application of
10 μM of the L-type Ca channel blocker nifedipine.
Despite its significant effect on contractility (see below),
nifedipine had no significant effect on either action poten-
tial amplitude or threshold, and triggered only a modest
reduction of dV/dt (Table 1). Taken together, these data
suggest sepsis-induced reduction in excitability is primar-
ily due to a reduction in Na current rather than changes
in either K or Ca currents.
Figure 1 Changes in action potentials suggest reduced Na current underlies reduced excitability. (a) Three representative papillary muscle
axon action potentials from healthy and septic rats are shown to demonstrate the range of amplitudes in each group. While the largest action potentials
from papillary muscle in septic rats were normal in amplitude, only 35% of action potentials overshot 0 mV; whereas in healthy papillary muscles, 73%
overshot 0 mV. In most traces, the stimulus artifact can be appreciated prior to the onset of the action potential. The horizontal line represents 0 mV.
(b) Superimposed on an expanded timescale are two action potentials from healthy rats (solid lines) and two action potentials from septic rats (dashed
lines). The action potentials from septic rats have reduced amplitudes and rate of rise, but are similar in duration to those from healthy rats. (c) Scatter
plots of animal means of action potential characteristics for eleven healthy and eight septic rats. Horizontal lines represent the mean for each group.
*P <0.05. AP, action potential; dV/dt, action potential rate of rise.
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is of interest, the most clinically relevant problem is
reduction of contractility. When ex vivo contractility
of papillary muscle from septic rats was measured, it
was reduced by greater than 70% (papillary muscle
force = 0.42 ± 0.08 grams in controls vs. 0.12 ± 0.02
grams in septic rats, P <0.05, n = 3 rats). We wished toTable 1 Characteristics of action potentials
Vrest (mV) APA (mV) AP threshold (mV) dV/dt
Healthy −79.9 ± 1.0 85.5 ± 1.8 −72.0 ± 0.5 59.6
Septic −78.3 ± 0.6 66.6 ± 5.6* −65.0 ± 1.8* 34.0
TTX Studies
Pre-TTX −77.5 ± 1.3 88.5 ± 4.2 −67.9 ± 2.5 57.1
Post-TTX −79.0 ± 2.4 69.1 ± 7.2 −54.6 ± 4.0* 22.1
Nifedipine studies
Pre-nifedipine −82.5 ± 2.3 89.2 ± 2.6 −70.5 ± 4.6 64.5
Post-nifedipine −85.2 ± 0.6 87.3 ± 2.0 −70.5 ± 2.7 52.4
Vrest, resting potential; APA, action potential amplitude; AP threshold, action potent
duration at 50% of the maximal amplitude. In healthy and septic studies *P <0.05 s
pretreatment vs. posttreatment (paired t test).determine whether reduction in Na current could be a
contributor to the reduced contractility induced by
sepsis. We measured force generation in papillary muscle
from healthy rats before and after application of 5 μM
TTX. Partial block of Na channels with 5 μM TTX
reduced cardiac contractility by 60% (Figure 2) and was
reversible following a 15 minute wash. This suggests that(mV/ms) APD 50 (ms) Number of rats studied (number of fibers)
± 2.4 32.7 ± 2.5 11 (84)
± 5.7* 29.1 ± 3.2 8 (108)
± 5.1 35.3 ± 3.9 3 (14)
± 8.1* 35.0 ± 0.5 3 (21)
± 5.0 38.5 ± 5.2 3 (15)
± 2.8* 34.3 ± 3.8 3 (22)
ial threshold; dV/dt, action potential rate of rise; APD 50, action potential
eptic vs. healthy (unpaired t test). In TTX and nifedipine studies *P <0.05
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an important contributor to reduction in contractility.
To determine the importance of Na current relative to
L-type Ca current in regulation of contractility, nifedipine
was applied. Application of 10 μM nifedipine reduced car-
diac contractility by 75% (Figure 2). Washout of nifedipine
was not as rapid as washout of TTX; but with a 1 to 2 hour
wash, the effect of nifedipine on contractility was largely
reversed. Our data suggest reduction of Na current trig-
gers a substantial reduction in contractility that is only
slightly less than the effect of reducing L-type Ca current.
Discussion
Downregulation of excitability during critical illness
We propose reduced excitability of electrically active
tissues is a unifying theme that accounts for the failure
of a number of organ systems during sepsis and critical
illness. Reduced excitability of peripheral nerve and
skeletal muscle has been demonstrated in both patients
and animal models of critical illness [1-4,6,7]. We recently
demonstrated reduced excitability of neurons within the
central nervous system in a rat model of sepsis [8]. If a
similar reduction in excitability occurs in the brain of
patients it could account for septic encephalopathy.
The current study further supports our hypothesis by
demonstrating reduced cardiac excitability in a rat model
of sepsis.
In both peripheral nerve and skeletal muscle the
mechanism underlying reduced excitability is reduction
in Na current. Evidence for reduction of Na current in
patients comes from studies demonstrating slowing of
muscle fiber conduction velocity and an increase in the
relative refractory period of both nerve and muscleFigure 2 Block of sodium channels triggers significant reduction in co
at 1 Hz before and after application of tetrodotoxin (TTX) and nifedipine. After
bar graph showing the mean force at baseline, following TTX, washout of TTX
(n = 3 rats). **P <0.01.[3,4,6]. In rats, more direct studies have demonstrated
increased inactivation of Na channels as the mechanism
underlying reduced excitability of both nerve and muscle
during sepsis [7,11]. The current study suggests Na current
may also be reduced in the heart. In the current study we
did not find evidence to suggest large changes in either Ca
channel or K channel function. This raises the possibility
that the reduction in Na current is due to a relatively
specific effect on Na channels rather than a generalized
effect on all ion channels.
There is evidence to suggest that Na current is especially
sensitive to cell sickness/injury. In studies of Na current in
intact skeletal muscle ex vivo, we found minor cell injury
during impalement triggers a dramatic hyperpolarized
shift in the voltage dependence of the Na current as
well as a reduction in maximal current density [20].
Similar shifts have been suggested to occur in injured
axons [31,32]. As different Na channel isoforms are present
in muscle and nerve, these data suggest that multiple
Na channel isoforms may react to cell injury with a hyper-
polarized shift in the voltage dependence of activation and
inactivation. In injured cells with a depolarized resting
potential, a hyperpolarized shift in the voltage dependence
of inactivation increases channel inactivation and thus
reduces Na current.
What function would be served by down regulation of
Na current during cell injury/illness? In heart it has been
shown that there is overlap of Na channel activation and
inactivation curves such that a Na ‘window’ current could
be triggered with depolarization of the resting potential, as
would occur during cell injury [33]. This current would
further depolarize the cell, and overload it with Na to
trigger an elevation of intracellular Ca due to reversentractility. (a) Shown are force traces from a papillary muscle paced
each drug is washed out, contractility returns to baseline. (b) Shown is a
(post TTX), following nifedipine, and washout of nifedipine (post Nifed)
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cellular Ca could then trigger cell death. One way to pre-
vent this cascade of events is to shut down Na current
so that cell depolarization, subsequent Na overload, and
Ca overload are limited. Shutting down Na current has
the cost of reducing excitability and thus temporarily
worsening cell function, but might promote cell survival.
Reduction of Na current by the cell might serve a similar
purpose to the use of barbituate coma in patients: by
decreasing metabolic demand during a period of cell stress
it might increase cell survival.
The relationship between reduced cardiac excitability and
contractility during sepsis
It is well established that during sepsis there is reduction
in cardiac contractility [13-16]. An important contribu-
tor to the reduction in contractility is reduction in the
action potential-induced Ca transient {Zhong, 1997 #5497},
[35-39]. However, the mechanism underlying the reduction
in Ca transient is not well established. Could reduction in
Na current contribute to the sepsis-induced reduction in
Ca transient and thus contribute to reduction in cardiac
contractility?
As intracellular Na does not play a direct role in excita-
tion contraction coupling, reduction in Na current is likely
having its effect on contractility via an effect on levels of
intracellular Ca. There are several ways reduction in the
density of functional Na channels might lessen the action
potential Ca transient. The first way is through a reduction
in the number of Ca channels that open during the action
potential. When Na current is reduced, there is reduction
in the peak depolarization reached during the action
potential. Reduction in depolarization will reduce Ca
channel opening and thus reduce Ca entry. One way this
might occur is through shortening of the action potential
such that Ca entry is reduced [40].
Alternatively, reduction in Na channels might reduce
propagation of action potentials into the t tubules such
that cardiac contractility is reduced [41]. Another way is
through a direct effect on Ca entry as it has been dem-
onstrated there is Ca entry through Na channels in rat
ventricular myocytes [42]. Finally, it has been found that
Na entry during the action potential is essential for efficient
triggering of SR Ca release [43-45]. The effect is proposed
to be mediated by temporary reverse operation of the
Na-Ca exchanger, which uses Na entry during the action
potential to prime the dyadic cleft with Ca [34,43-45].
These mechanisms may explain the dramatic reduction
in contractility we found following partial block of Na
channels in healthy papillary muscle. We conclude reduc-
tion in cardiac Na current during sepsis may be an import-
ant contributor to reduction in contractility.
There are several limitations to this study. (1) We used
a rat model of sepsis, which may not faithfully mimicconditions in patients with critical illness. (2) As we used
intact, beating, papillary muscle freshly isolated from
rats, it was not possible to perform patch clamp studies to
directly measure Na and Ca currents. Such studies would
necessitate use of in vitro models of sepsis using cultured
cardiac myocytes. A first step would be to determine
whether the finding of reduced cardiac excitability can
be recreated in a reduced system in vitro. (3) We did
not attempt to determine the sodium channel subtype
that is affected by sepsis. It has been reported that the
heart expresses multiple subtypes of sodium channels
that may play a role in contractility [41].
Conclusions
The present findings indicate that in a rat model of sepsis
there is a reduction in cardiac excitability that appears
to be due to reduction in Na current. Partial block of
Na channels greatly reduced contractility in healthy heart
muscle. Together these data suggest that reduction of Na
current during sepsis may be a significant contributor to
reduction of cardiac contractility. Determining the mech-
anism underlying reduction in Na current might allow for
therapy to improve cardiac contractility during sepsis.
Key messages
 Cardiac excitability is reduced during sepsis in rats.
 The reduction in excitability appears to be primarily
due to reduction of sodium current.
 The reduction in sodium current may be sufficient
to explain most of the reduction in cardiac
contractility during sepsis.
 Reduced excitability of electrically active tissues may
be a unifying theme that accounts for the failure of a
number of organ systems during sepsis and critical
illness.
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